Lifeward (LFWD) Amortization of Deferred Charges (2025 - 2026)
Lifeward (LFWD) reported Amortization of Deferred Charges of $53000.0 for Q1 2026, down 41.76% on a YoY basis from $91000.0 in Q1 2025, and down 41.76% sequentially from $91000.0 in Q1 2025.
Lifeward (LFWD) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
Lifeward (LFWD) has 2 years of Amortization of Deferred Charges data on file, last reported at $53000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 176.62 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.72 Bn | 99.50 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.85 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn |
| 10 | Lifeward | 11.44 Mn | 15,879.75 | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,000.00 |
| Mar 31, 2026 | 53,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Mar 31, 2025 | 91,000.00 |